PTEN and TP53 co-mutation, typical of a subset of anaplastic carcinomas, has been proven to dysregulate cell cycle and metabolism, thus promoting anaplastic transformation in mouse models (143). The gene discussed is TP53; the disease is undifferentiated carcinoma.